Answer
Xeplion (paliperidone palmitate) should not be used during pregnancy unless clearly necessary, as adequate pregnancy data are lacking; third-trimester exposure risks neonatal extrapyramidal and/or withdrawal symptoms of varying severity and duration, so newborns should be monitored carefully.
Sources for this answer
- XEPLION 150 mg prolonged release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked